NRX Pharmaceuticals, Inc. (NRXP)
2.705
+0.12
(+4.44%)
USD |
NASDAQ |
Oct 15, 16:00
2.705
0.00 (0.00%)
After-Hours: 16:40
NRX Pharmaceuticals EPS Diluted (Quarterly) : -0.4388 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4388 |
| March 31, 2026 | -0.0442 |
| December 31, 2025 | 0.0113 |
| September 30, 2025 | -0.2649 |
| June 30, 2025 | -0.9803 |
| March 31, 2025 | -0.3359 |
| December 31, 2024 | -0.773 |
| September 30, 2024 | -0.1479 |
| June 30, 2024 | -0.7508 |
| March 31, 2024 | -0.7374 |
| December 31, 2023 | -0.5173 |
| September 30, 2023 | -0.7397 |
| June 30, 2023 | -1.190 |
| March 31, 2023 | -1.636 |
| December 31, 2022 | -1.541 |
| September 30, 2022 | -1.367 |
| June 30, 2022 | -1.062 |
| March 31, 2022 | -2.112 |
| Date | Value |
|---|---|
| December 31, 2021 | -5.236 |
| September 30, 2021 | -4.069 |
| June 30, 2021 | -65.14 |
| March 31, 2021 | -7.148 |
| December 31, 2020 | -10.50 |
| September 30, 2020 | -1.512 |
| June 30, 2020 | 0.0279 |
| March 31, 2020 | 0.9605 |
| December 31, 2019 | -0.0286 |
| September 30, 2019 | 0.0977 |
| June 30, 2019 | 0.2548 |
| March 31, 2019 | 0.2096 |
| December 31, 2018 | 0.0322 |
| September 30, 2018 | 0.0311 |
| June 30, 2018 | -0.0073 |
| March 31, 2018 | 0.0172 |
| December 31, 2017 | -0.1149 |
| September 30, 2017 | -0.0013 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.52M |
| Revenue (Quarterly) | 1.101M |
| Total Expenses (Quarterly) | 17.62M |
| Enterprise Value | 86.34M |
| Gross Profit Margin (Quarterly) | 23.43% |
| Profit Margin (Quarterly) | -1.50K% |
| Earnings Yield | -27.23% |
| Normalized Earnings Yield | -19.64 |